News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Drug Development Company Glycotek Moves into the Hershey Center for Applied Research


11/10/2008 10:57:16 AM

HERSHEY, Pa.--(BUSINESS WIRE)--The Hershey Center for Applied Research (HCAR) announced today that Glycotek, LLC has established its laboratory on the HCAR campus, Building One. Glycotek is developing a technology that will contribute to clinical medicine a long-sought alternative to heparin which currently must be administered in a hospital setting. A glycosaminoglycan (GAG) technology will be used to develop oral alternatives to heparin, for the treatment of deep vein thrombosis and other thrombotic conditions, and also cancer. The company will pursue both business and research and development activities at HCAR, building upon the activities already in progress at its New York location.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES